PDZD2 Antikörper (AA 1-11)
Kurzübersicht für PDZD2 Antikörper (AA 1-11) (ABIN1885573)
Target
Alle PDZD2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-11
-
Aufreinigung
- Purified by antigen-affinity chromatography.
-
Immunogen
- Synthetic peptide contain a sequence corresponding to a region within amino acids 1 and 11 (O15018) of PDZK3
-
-
-
-
Applikationshinweise
-
Suggested dilutions:
Western blotting: 1.500-1.3000 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- 0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
-
Konservierungsmittel
- Thimerosal (Merthiolate)
-
Vorsichtsmaßnahmen
- Biohazard Informations: This product contains thimerosal which is hazardous.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
-
-
- PDZD2 (PDZ Domain Containing 2 (PDZD2))
-
Andere Bezeichnung
- PDZK3
-
Hintergrund
-
Proteins containing PDZ domains have been shown frequently to bind the C-termini of transmembrane receptors or ion channels.They have also been shown to bind to other PDZ domain proteins and could possibly be involved in intracellular signalling.The protein encoded by this gene contains six PDZ domains and shares sequence similarity with pro-interleukin-16 (pro-IL-16).Like pro-IL-16, the encoded protein localizes to the endoplasmic reticulum and is thought to be cleaved by a caspase to produce a secreted peptide containing two PDZ domains.In addition, this gene is upregulated in primary prostate tumors and may be involved in the early stages of prostate tumorigenesis.[provided by RefSeq]
-
Molekulargewicht
- 302 kDa
-
Gen-ID
- 23037
-
NCBI Accession
- NM_178140, NP_835260
Target
-